Skip to content

A clinical trial to study the effects of lakshadi taila shiropichu and jatamansyadi taila pratimarsha nasya in the management of attention deficit hyperactivity disorder in children.

Evaluation of lakshadi taila shiropichu and jatamansyadi taila pratimarsha nasya in the management of attention deficit hyperactivity disorder in children-a randomised controlled clinical trial - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067151
Enrollment
30
Registered
2024-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F078- Other personality and behavioral disorders due to known physiological condition

Interventions

None listed

Sponsors

KLE Ayurveda Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children fulfilling the diagnostic criteria will be included for the study. Children of either sex between the age group of 6-16 years.

Exclusion criteria

Exclusion criteria: Children with an acute or chronic, local or systemic infection will be excluded. Children who are currently using other medications will be excluded owing to the possibility of drug interaction. Known case of cerebral palsy, mental retardation, epilepsy and hearing defect etc. Children with obvious congenital anomalies Children who have received any form of modern intervention for ADHD in last 1 month

Design outcomes

Primary

MeasureTime frame
There might be an effect of Lakshadi taila Shiropichu and Jatamansyadi taila Pratimarsha Nasya in the management of ADHD in children which shall be assessed with Vanderbilt ADHD diagnostic parent rating scaleTimepoint: 0th day,7th day,30th day

Secondary

MeasureTime frame
There might be a significant effect of Lakshadi taila Shiropichu & Jatamansyadi taila Pratimarsha Nasya by the end of 30 days in children with ADHD which will be assessed by ADHD IMPACT MODULE-CHILD & Pediatric Quality of life InventoryTimepoint: 0th day,7th day,30th day

Countries

India

Contacts

Public ContactDr Aziz Arbar

KAHER Shri BMK Ayurveda Mahavidyalaya

azizarbar@gmail.com9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026